Showing results (1141-1150 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|May 10, 2020
Peripheral spondyloarthritis: a neglected entity-state of the artPhilippe Carron, Ann-Sophie De Craemer, Filip Van den Bosch
RMD Open|January 4, 2023
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patientsJosé Luis Martín-Varillas, Lara Sanchez-Bilbao, Vanesa Calvo-Río, et al.
RMD Open|January 4, 2023
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-upMichaela Koehm, Sarah Ohrndorf, Ann C Foldenauer, et al.
RMD Open|January 4, 2023
Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic reviewMaike H M Wientjes, Alfons A den Broeder, Paco M J Welsing, et al.
RMD Open|January 4, 2023
Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS)Laura Pina Vegas, Léa Hoisnard, Léa Bastard, et al.
RMD Open|January 4, 2023
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)Giovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
RMD Open|January 12, 2023
Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature reviewAna De Vicente Delmás, Lara Sanchez-Bilbao, Vanesa Calvo-Río, et al.
RMD Open|January 17, 2023
Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort studyWilliam Tillett, Alexis Ogdie, Alun Passey, et al.
RMD Open|January 20, 2023
Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020Katinka Albrecht, Anja Strangfeld, Ursula Marschall, et al.
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
Pageof 192